associate director
Recently Published Documents


TOTAL DOCUMENTS

333
(FIVE YEARS 15)

H-INDEX

5
(FIVE YEARS 1)

2021 ◽  
pp. 1-9
Author(s):  
Elliot R. Siegel

Friends and colleagues of Donald A.B. Lindberg M.D. came together to give tribute to his extraordinary contributions during his tenure (1984–2015) as Director of the U.S. National Library of Medicine (NLM). Dr. Lindberg died in 2019. The book, Transforming biomedical informatics and health information access: Don Lindberg and the U.S. National Library of Medicine. includes four sections. The ten edited chapters in section three (the Outreach section) are briefly summarized in this overview. As Associate Director for Health Information Programs Development, Elliot R. Siegel Ph.D. coordinated NLM’s outreach programming under Dr. Lindberg’s leadership from its inception in 1989 to his own retirement in 2010. Dr. Lindberg’s legacy at NLM is one of new possibilities imagined, significant changes made in the mission and ethos of a venerable institution, and numerous successes achieved in a variety of settings and contexts. Like so much else Dr. Lindberg accomplished, these Outreach programs that profoundly changed the character of NLM would likely not have occurred without him. He made a difference.


2021 ◽  
Vol 11 (11) ◽  
pp. 1967-1971 ◽  
Author(s):  
Barbara K Rimer

Abstract At the beginning of Dr. Robert Croyle’s 18th and final year as director of the National Cancer Institute’s (NCI) Division of Cancer Control and Population Sciences (DCCPS), before his retirement in December 2021, it is fitting to review some of his and the division’s many accomplishments and pay tribute to him as one of the government’s most effective leaders. The focus of this article is on Dr. Croyle’s contributions in the behavioral and related domains and his and the division’s impact on the landscape of cancer control and population sciences. Dr. Croyle joined DCCPS in 1998 as associate director for behavioral research. He became acting director of DCCPS in 2001 and then director in 2003. DCCPS is a formidable NCI division, with broad mandates and responsibilities and many partners from multiple sectors. The division conducts and supports an integrated program of the highest-quality genetic, epidemiological, behavioral, social, applied, survivorship, surveillance, and health care delivery cancer research. The division’s notable successes in implementation science and the dissemination of evidence-based findings and products, use of cancer research consortia, and partnerships across National Institutes of Health and with external federal and nongovernmental organizations are among many that reflect Dr. Croyle’s visionary leadership.


Early China ◽  
2021 ◽  
Vol 44 ◽  
pp. 13-18
Author(s):  
Feng Li

AbstractZhang Changshou was one of the most important archaeologists of modern China, and a founder of Western Zhou archaeology. Zhang is particularly well known as the author of a series of works that established the chronology of the Western Zhou material culture and is esteemed for his excellent scholarship also on bronzes and jade objects, characterized by a strong basis in field archaeology. Among his academic appointments are Director of the Feng-Hao Archaeological Team in 1963–1988, and Associate Director of the Institute of Archaeology (Chinese Academy of Social Sciences) in 1985–1988. Zhang was also a pioneer of Sino-American collaboration (with Harvard University) in field archaeology and was elected a Corresponding Member of the German Archaeological Institute in 1988. Zhang passed away in Beijing on January 30, 2020. This article summarizes his academic accomplishments.


2021 ◽  
pp. 1-19
Author(s):  
Alexandra Erath

Study level/applicability This case is appropriate for use in undergraduate and MBA courses. Subject area This case can be used in courses in business ethics, leading teams and organizations or business strategy. The focus of the case aligns well with discussions of managing up, navigating changes in top leadership and conflicts between executive vision and future company growth. Instructors that choose to emphasize the ethical approach could assign this case to explore tradeoffs between loyalty to current and future bosses. Case overview Associate Director of Forecasting Cindy March faces a multi-faceted dilemma as biotech firm Veracity’s acquisition date by pharmaceutical giant Makhola approaches. After a new competitor enters the market, March expects Veracity drug Sangren’s future revenue to drop to $600m in 2019, but the outgoing Veracity CEO refuses to accept a forecast of less than $700m. March suspects that the CEO is intent on handing over a financially successful company and is overly optimistic about Sangren’s ability to maintain market share. In two weeks, March is due to present a 2019 Sangren forecast to incoming Makhola leadership, who she anticipates becoming her direct boss after the acquisition. Should March present the inflated forecasts and accept the poor reflection on her professional abilities or should she refuse to present numbers she does not believe in? Expected learning outcomes By analyzing and discussing the case, students should be able to:Evaluate the potential business and ethical conflicts arising from decision-making based on both data and intuition. Synthesize an appropriate strategy for navigating tradeoffs between current and future leadership.Analyze the gender dynamics of male-dominated executive leadership structures and strategies for female employees to combat gender biases. Supplementary materials The Behavioral Science Guys, 2015. One Simple Skill to Curb Unconscious Gender Bias. YouTube. https://www.youtube.com/watch?v=SEHi4yauhu8&ab_channel=VitalSmartsVideoTeaching Notes are available for educators only. Please contact your library to gain login details or email [email protected] to request teaching notes. Subject code CSS 6: Human resources.


2021 ◽  
Vol 218 (5) ◽  
Author(s):  
Alina Baum ◽  
Christos A. Kyratsous

Christos Kyratsous, Vice President of Research, Infectious Diseases, and Viral Vector Technologies at Regeneron Pharmaceuticals, and Alina Baum, Associate Director, Infectious Diseases Associate at Regeneron Pharmaceuticals, discuss the development of antibody therapeutics targeting the spike protein of SARS-CoV-2.


2021 ◽  
Vol 12 (1) ◽  
pp. 8-10
Author(s):  
Aránzazu Berbey Álvarez

Dr. Sanjur’s relationship with the Smithsonian Tropical Research Institute spans three decades.    In 1989, she was a research assistant for two years working on her undergraduate thesis project. After earning a B.S. in Biology from the University of Panama, she completed a PhD in Cell and Developmental Biology at Rutgers, the State University of New Jersey.  She returned to STRI as a postdoctoral fellow in 1998, studying the relationships between wild and domesticated crops such as squash and pumpkin.    She then spent ten years as manager and researcher of the Molecular Evolution laboratory, after which she took on her most recent role as Associate Director for Science Administration at STRI. In this position, she became responsible for maintaining high standards of scientific operational support for the Institute’s research programs throughout a decade.


2021 ◽  
Vol 82 (1) ◽  
pp. 132
Author(s):  
Danya Leebaw

Christine Bombaro’s edited volume, Diversity, Equity, and Inclusion in Action: Planning, Leadership, and Programming, is thoughtful, useful, and timely. Bombaro, associate director at the Dickinson College library, introduces this compilation by framing as a moral problem the gap between academic librarianship’s stated goals around diversity, equity, and inclusion (DEI) and its actual record. She argues that we must move beyond “merely trying our best” to actually “getting it right” (xii). Bombaro’s introduction and the first chapter serve to ground the book with historical and theoretical context around DEI in academic libraries and argue persuasively that we must move past dialogue to taking action. The chapters that follow offer case studies by academic library practitioners who describe actions taken in their institutions. Each chapter follows a similar structure, with literature reviews, case details, discussion, and careful footnoting. This book covers topics that include organizational goals and plans around DEI, developing cultural competencies for library staff, barriers to workforce diversity, and the development of models for how libraries can better serve the diverse communities with whom we work.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 684-684
Author(s):  
Erica Solway

Abstract The fourth speaker is Dr. Erica Solway. Dr. Solway will discuss her experience working in policy at the federal level as a Health and Aging Policy Fellow and a policy advisor with the U.S. Senate Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Aging and in her current involvement in policy-relevant research at the state and national level at the University of Michigan Institute for Healthcare Policy & Innovation. Dr. Solway is a senior project manager forthe evaluation of the Healthy Michigan Plan, Michigan’s Medicaid expansion program, and is also an associate director of the University of Michigan National Poll on Healthy Aging.


Bioanalysis ◽  
2020 ◽  
Vol 12 (13) ◽  
pp. 869-872
Author(s):  
Remco A Koster

RA Koster currently works as Associate Director of Bioanalytical Science at the LC–MS/MS department at PRA Health Sciences in the Laboratory in Assen, The Netherlands. He is responsible for the LC–MS/MS analytical method development and leads a team of method development analysts and scientists. As global microsampling specialist within PRA he is interested in all developments regarding microsampling and aims to continuously improve microsampling techniques. He has been working in the field of bioanalysis for 19 years, in which he performed and supervised numerous analytical method developments using LC–MS/MS. He started his career in 2001 at Pharma Bio-Research (before it was acquired by PRA) as an LC–MS/MS analyst. In 2005, he moved to the University Medical Center Groningen where he focused on the development and validation of analytical methods for drugs and drugs of abuse in matrices like blood, plasma, hair, saliva, dried blood spots and volumetric absorptive microsampling with LC–MS/MS. In 2015 he obtained his PhD on the subject ‘The influence of the sample matrix on LC–MS/MS method development and analytical performance’. In 2017, he started as Senior Scientist at PRA Health Sciences and in 2019, he accepted his current role of Associate Director of Bioanalytical Science. He is a (co-)author of more than 35 publications.


Mediaevistik ◽  
2020 ◽  
Vol 32 (1) ◽  
pp. 266-267
Author(s):  
Albrecht Classen

This catalog accompanies a fascinating and innovative exhibition documenting the art in medieval Saharan Africa, first shown at the Block Museum of Art, Northwestern University, Evanston, IL, from Jan. 26 to July 21, 2019, then at The Aga Khan Museum, Toronto, from Sept. 21 2019 to Feb. 23, 2020, and finally at the National Museum of African Art, Smithsonian Institution, Washington, DC, April 8 to Nov. 29, 2020. To bring all those very valuable objects together and to organize this exhibit, represents a major task involving many people. Here I want to concentrate only on the catalog itself, magisterially edited by Kathleen Bickford Berzock, Associate Director of Curatorial Affairs, Block Museum of Art.


Sign in / Sign up

Export Citation Format

Share Document